Closed · RFA-HL-11-013 · CFDA 93.395;93.839 · Discretionary
Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Core Clinical Centers (U10)
Federal grant opportunity posted by National Institutes of Health, cataloged on Grants.gov.
- up to $115K
- Award range
- Closed
- Status
- October 13, 2010
- Close date
- -
- Expected awards
The verdict
Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Core Clinical Centers (U10) is a closed discretionary listing from National Institutes of Health that offered Up to $115,000. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 12,419 other opportunities from National Institutes of Health.
- up to $115K
- award range
- Closed
- application status
- 93.395;93.839
- CFDA program
- 12,419
- other opportunities from National Institutes of Health
Archived opportunity record
Blood and Marrow Transplant Clinical Trials N… is closed (last close October 13, 2010). Check the agency catalog for replacement NOFOs. National Institutes of Health still indexes 12,419 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed October 13, 2010
Instrument
Cooperative Agreement
Description
Purpose. This Funding Opportunity Announcement (FOA) issued by the National Heart, Lung, and Blood Institute (NHLBI) and the National Cancer Institute (NCI), National Institutes of Health, invites applications from investigators willing to participate under a cooperative agreement as Core Clinical Centers in the Blood and Marrow Transplant Clinical Trials Network (BMT CTN), a collaborative multicenter clinical program that promotes the efficient comparison of novel treatment approaches and management strategies for potential benefit of children and adults undergoing hematopoietic stem cell transplantation. This is an open competition for the renewal of an existing network. Mechanism of Support. This FOA will utilize the U10 NIH Cooperative Clinical Research Agreement grant mechanism. Funds Available and Anticipated Number of Awards. NHLBI and NCI intend to commit up to $63.5 million over six years to fund up to 19 Core Clinical Centers with expertise in hematopoietic stem cell transplantation (HSCT) and a Data Coordinating Center (DCC) to support the program. Investigators interested in applying as DCC for the BMT CTN program should refer to the companion Request for Applications (RFA-HL-11-028).
Market-open applicant set · includes for-profit door
The eligibility set for Blood and Marrow Transplant Clinical Trials N… includes a for-profit door among 6 printed types (Public / state-controlled institutions of higher education; Nonprofits with 501(c)(3) status (other than IHEs); Nonprofits without 501(c)(3) status (other than IHEs); Private institutions of higher education; +2 more). Competitive traffic can include commercial applicants alongside other listed classes. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity codes span Education · Health (ED;HL). Only 50 other National Institutes of Health listings share this exact eligibility-code string (0% of 12,420).
- Code 06
- Public / state-controlled institutions of higher education
- Code 12
- Nonprofits with 501(c)(3) status (other than IHEs)
- Code 13
- Nonprofits without 501(c)(3) status (other than IHEs)
- Code 20
- Private institutions of higher education
- Code 22
- For-profit organizations other than small businesses
- Code 25
- Others (see official listing text)
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
More from National Institutes of Health
Validation Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U54 Clinical Trials Not Allowed)
Logistics Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U24 Clinical Trials Not Allowed)
Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)
PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional)
Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional)
What to do next
Blood and Marrow Transplant Clinical Trials N… is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 93.395;93.839 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- National Institutes of Health lists 12,419 other indexed opportunities on PlainGrants. Agency catalog
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |